EE345 Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2-Months Is Cost Effective for the Treatment of HIV-1 in Spain

Autor:	S Moreno Guillén, A Rivero, P Ventayol, V Falcó, M Torralba, M Schroeder, V Neches, LA Vallejo-Aparicio, I Mackenzie, M Turner, C Harrison
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S122
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.09.591
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::483eaeb035089bac0b2369e1b834e89d https://doi.org/10.1016/j.jval.2022.09.591 Zobrazit plný text záznamu Full Text from ScienceDirect